Genteel alternate-site lancet device gains FDA clearance

MIDLAND, Texas — Genteel on Tuesday announced clearance by the U.S. Food & Drug Administration for its “gentle” lancing device. Genteel is the only FDA-cleared standalone lancing device that performs ample blood draw from other body sites as well as fingers.



“Genteel provides a new approach to help people safely and comfortably check glucose levels from multiple convenient body sites, not just fingers, with absolutely no discomfort," stated Christopher Jacobs, inventor of the product. "Because it’s designed to be painless, Genteel is especially helpful in monitoring children’s blood sugar levels, and now provides a way for parents to check their child’s blood sugar at night without disturbing their all-important sleep.”



According to clinical studies, the palm of the hand has the same blood flow as fingers, and provides an accurate alternative site to constant finger stick “poking.” This allows those with diabetes to “give fingers a break” and let their sore, calloused fingers heal. Other lancing devices that claim “alternate site testing” often require squeezing to get enough blood for test meters, which can cause soreness, sensitivity or bruising. Using Genteel’s vacuum, a blood drop is brought to the surface without additional effort. Genteel also has the ability to “re-draw” blood from test sites as needed throughout the day without needing the skin to be re-punctured.



Genteel also announced the launch of its new website, www.mygenteel.com, featuring videos of children and adults checking blood sugar levels without pain, professional reviews, and a secure online ordering system. Genteel is also stocked on Amazon Prime, and is available for overnight or 2-day delivery.